• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Sirtex Medical Ltd

+ Add to Watchlist


17.4900 USD 0.2500 1.41%

As of 20:10:00 ET on 07/18/2014.

Snapshot for Sirtex Medical Ltd (SXMDF)

Open: 17.5599 Day's Range: 17.3900 - 17.5599 Volume: 3,260
Previous Close: 17.7400 52wk Range: 9.8000 - 17.7400 1-Yr Rtn: -

Stock Chart for SXMDF

No chart data available.
  • SXMDF:US 17.4900
  • 1D
  • 1M
  • 1Y
Interactive SXMDF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SXMDF

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 43.0740
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) 0.4310
Est. PEG Ratio 1.3940
Market Cap (M USD) 988.09
Shares Outstanding (M) 56.49
30 Day Average Volume 318
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.92%
Cash Dividend (AUD) 0.1200
Dividend Ex-Date 10/04/2013
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SXMDF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for SXMDF

Sirtex Medical Limited is a medical company which researches, develops and commercializes medical products for the treatment of liver cancer. The Company is based in Western Australia and markets its products throughout the world. The Company's products include "SIR-Spheres," which uses micro-particle technology to treat liver cancer.

Gilman WongCEO/Executive DirectorDarren SmithCFO/Secretary
David CadeChief Medical OfficerNigel LangeCEO:Europe
More Company Profile & Key Executives for SXMDF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil